000			04378nam a22004215i 4500
999			_c362547 _d362547 _x1
001			362547
003			ES-MaUEC
005			20230102121552.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210701s2021 sz | s |||| 0|eng d
020			_a9783030691868
024	7		_a10.1007/978-3-030-69186-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM666.C266 _b2021 EB
245	0	0	_aCannabinoids and Pain _cedited by Samer N. Narouze
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XIX, 339 páginas) _b60 ilustraciones, 47 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aHistory of Cannabis -- Cannabis Regulations -- The demand for medical cannabis education -- Pain physicians and cannabis: attitudes and beliefs -- Cannabis Terminology -- The Endocannabinoid System -- The CB1 Receptors -- The CB2 Receptors -- Endocannabinoids: Anandamide and 2-AG -- Phytocannabinoids:Tetrahydrocannabinol (THC) -- Phytocannabinoids: Cannabidiol (CBD) -- Other Phytocannabinoids -- Cannabinoids Drug interaction -- Dronabinol (Marinol) -- Nabilone (Cesamet) -- Cannabidiol (Epidiolex) -- Nabiximols (Sativex) -- Medical Cannabis Strains -- The model of a specialized cannabis clinic -- Barriers for the prescription of cannabis-based medicines -- Practical recommendations for the use of medical cannabis -- Medical Cannabis Dosing and Titration -- Patient safety considerations -- Cannabinoids and Pain: Mechanisms of action -- Cannabinoids and Pain: Clinical Evidence -- Cannabinoids and Cancer Pain -- Cannabinoids as a substitute for opioids: Basic science and Clinical evidence -- Cannabiinoids as a substitute for opioids: Suggested algorithm -- Perioperative management of patients on cannabinoids -- The Colorado Experience -- Product Safety and Quality control -- Cannabis and brain development -- Cannabis and mental health risks -- Cannabis and adolescents -- Cannabis and child development during and after pregnancy -- Cannabis impairment and Adverse events -- Vaping hazards -- Cannabis Use Disorder -- Cannabis withdrawal -- Future research.
520			_aThis book presents a well-balanced view of the potential medical use of cannabinoids in pain. It comprehensively covers the current challenges with medical cannabis utilization and provides recommendations for research and future directions. Organized into nine sections, the book begins with an introduction to medical cannabis, including its history, regulations, and the general attitudes of pain physicians on cannabis. Section two explores the biological effects of marijuana via the endocannabinoid system and its complex structure of receptors and enzymes. Sections three, four, and five then delve further into pharmacology and the mechanisms of action applicable to cannabinoids in managing pain. Timely and socially conscious, section six examines the benefits of substituting opioids with cannabinoids for preoperative management. Echoing the book's well-rounded content, sections seven and eight consider the challenges with medical cannabis, including safety and quality control, brain development risks, vaping hazards, and withdrawal. The book then closes with a look at the future of cannabis in medical research. Thoroughly and equitably composed, Cannabinoids and Pain is an invaluable resource for primary care physicians, pain and palliative care physicians, and oncologists.
988			_aSpringer_Medicine_2021
650		7	_2embne _aDolor _xQuimioterapia _9137881
650		7	_2embne _9262120 _aCannabis _xUso terapéutico
700			_aN. Narouze, Samer _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _988240
776	0	8	_iPrinted edition: _z9783030691851
776	0	8	_iPrinted edition: _z9783030691875
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-69186-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _esc _zSI